• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
Back

Corporate News

GlaxoSmithKline Pharmaceuticals Limited reports certificate compliance with SEBI regulations
12-Oct-2026, 05:04

GlaxoSmithKline Pharmaceuticals Limited informed the BSE Limited and the National Stock Exchange of India Limited that it has received a certificate from Kfin Technologies Limited, its Registrar and share Transfer Agent, for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.